» Authors » Roelant S Eijgelaar

Roelant S Eijgelaar

Explore the profile of Roelant S Eijgelaar including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 153
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Majewska P, Holden Helland R, Ferles A, Pedersen A, Kommers I, Ardon H, et al.
J Neurosurg . 2025 Jan; 1-9. PMID: 39823581
Objective: The extent of resection (EOR) and postoperative residual tumor (RT) volume are prognostic factors in glioblastoma. Calculations of EOR and RT rely on accurate tumor segmentations. Raidionics is an...
2.
Pemberton H, Wu J, Kommers I, Muller D, Hu Y, Goodkin O, et al.
Sci Rep . 2023 Nov; 13(1):18911. PMID: 37919354
This study tests the generalisability of three Brain Tumor Segmentation (BraTS) challenge models using a multi-center dataset of varying image quality and incomplete MRI datasets. In this retrospective study, DeepMedic,...
3.
Holden Helland R, Ferles A, Pedersen A, Kommers I, Ardon H, Barkhof F, et al.
Sci Rep . 2023 Nov; 13(1):18897. PMID: 37919325
Extent of resection after surgery is one of the main prognostic factors for patients diagnosed with glioblastoma. To achieve this, accurate segmentation and classification of residual tumor from post-operative MR...
4.
Bouget D, Pedersen A, Jakola A, Kavouridis V, Emblem K, Eijgelaar R, et al.
Front Neurol . 2022 Aug; 13:932219. PMID: 35968292
For patients suffering from brain tumor, prognosis estimation and treatment decisions are made by a multidisciplinary team based on a set of preoperative MR scans. Currently, the lack of standardized...
5.
Van der Voort S, Incekara F, Wijnenga M, Kapsas G, Gahrmann R, Schouten J, et al.
Neuro Oncol . 2022 Jul; 25(2):279-289. PMID: 35788352
Background: Accurate characterization of glioma is crucial for clinical decision making. A delineation of the tumor is also desirable in the initial decision stages but is time-consuming. Previously, deep learning...
6.
Lai Y, Boer C, Eijgelaar R, van den Brom C, de Witt Hamer P, Schober P
J Neurosurg . 2021 Oct; 136(6):1560-1566. PMID: 34678766
Objective: Awake craniotomies are often characterized by alternating asleep-awake-asleep periods. Preceding the awake phase, patients are weaned from anesthesia and mechanical ventilation. Although clinicians aim to minimize the time to...
7.
Bouget D, Eijgelaar R, Pedersen A, Kommers I, Ardon H, Barkhof F, et al.
Cancers (Basel) . 2021 Sep; 13(18). PMID: 34572900
For patients with presumed glioblastoma, essential tumor characteristics are determined from preoperative MR images to optimize the treatment strategy. This procedure is time-consuming and subjective, if performed by crude eyeballing...
8.
Muller D, Robe P, Ardon H, Barkhof F, Bello L, Berger M, et al.
J Neurosurg . 2021 Jul; 136(1):45-55. PMID: 34243150
Objective: The aim of glioblastoma surgery is to maximize the extent of resection while preserving functional integrity. Standards are lacking for surgical decision-making, and previous studies indicate treatment variations. These...
9.
Kommers I, Bouget D, Pedersen A, Eijgelaar R, Ardon H, Barkhof F, et al.
Cancers (Basel) . 2021 Jul; 13(12). PMID: 34201021
Treatment decisions for patients with presumed glioblastoma are based on tumor characteristics available from a preoperative MR scan. Tumor characteristics, including volume, location, and resectability, are often estimated or manually...
10.
Muller D, De Swart M, Ardon H, Barkhof F, Bello L, Berger M, et al.
Neurooncol Adv . 2021 May; 3(1):vdab053. PMID: 34056605
Background: The impact of time-to-surgery on clinical outcome for patients with glioblastoma has not been determined. Any delay in treatment is perceived as detrimental, but guidelines do not specify acceptable...